Noble Capital Starts NanoViricides (NNVC) at Outperform
Noble Capital analyst Robert LeBoyer initiates coverage on NanoViricides (NYSE: NNVC) with a Outperform rating and a price target of ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
